Multiple sclerosis and Therapeutic response delayed

Summary:

Therapeutic response delayed is found among people with Multiple sclerosis, especially for people who are male, 50-59 old.

The study analyzes which people have Therapeutic response delayed with Multiple sclerosis. It is created by eHealthMe based on reports of 17 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Therapeutic response delayed?

Therapeutic response delayed (late preventive response) is found to be associated with 239 drugs and 366 conditions by eHealthMe. Check the latest studies of Therapeutic response delayed.

On Jul, 15, 2026

17 people who have Multiple Sclerosis and Therapeutic Response Delayed are studied.

Would you have Therapeutic response delayed when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Therapeutic Response Delayed *:

female: 50 %
male: 50 %

Age of people who have Multiple Sclerosis and experienced Therapeutic Response Delayed *:

Common co-existing conditions for these people *:

Type 2 Diabetes: 1 person, 5.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Memory Loss: 4 people, 23.53%
Diarrhea: 4 people, 23.53%
Nervousness: 4 people, 23.53%
Fear: 4 people, 23.53%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 3 people, 17.65%
Dizziness: 3 people, 17.65%
Limb Discomfort (discomfort in leg): 3 people, 17.65%
Insomnia (sleeplessness): 3 people, 17.65%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 17.65%
Fatigue (feeling of tiredness): 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Therapeutic response delayed?

- Check whether Therapeutic response delayed is associated with a drug or a condition

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Therapeutic response delayed and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.